Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
ACS Chemical Biology|November 26, 2010
Transcript profiling and RNA interference as tools to identify small molecule mechanisms and therapeutic potentialRahul Palchaudhuri, Paul J HergenrotherBioorganic & Medicinal Chemistry Letters|August 20, 2008
Triphenylmethylamides (TPMAs): Structure-activity relationship of compounds that induce apoptosis in melanoma cellsRahul Palchaudhuri, Paul J HergenrotherCurrent Opinion in Biotechnology|November 9, 2007
DNA as a target for anticancer compounds: methods to determine the mode of binding and the mechanism of actionRahul Palchaudhuri, Paul J HergenrotherJournal of the American Chemical Society|July 10, 2008
The complex role of the triphenylmethyl motif in anticancer compoundsRahul Palchaudhuri, Vitaliy Nesterenko, Paul J HergenrotherJournal of the American Chemical Society|March 30, 2010
Chemistry and biology of deoxynyboquinone, a potent inducer of cancer cell deathJoseph S Bair, Rahul Palchaudhuri, Paul J HergenrotherInvestigational New Drugs|February 20, 2010
Cribrostatin 6 induces death in cancer cells through a reactive oxygen species (ROS)-mediated mechanismMirth T Hoyt, Rahul Palchaudhuri, Paul J HergenrotherThe Journal of Allergy and Clinical Immunology|August 11, 2023
Transplantation after CD45-ADC corrects Rag1 immunodeficiency in congenic and haploidentical settingsFrancesca Pala, Cristina Corsino, Enrica Calzoni, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 18, 2011
Triphenylmethyl derivatives enhances the anticancer effect of immunotoxinsKarianne Risberg, Ingrid Jenny Guldvik, Rahul Palchaudhuri, et al.Journal of Medicinal Chemistry|March 26, 2010
N-((1-benzyl-1H-1,2,3-triazol-4-yl)methyl)arylamide as a new scaffold that provides rapid access to antimicrotubule agents: synthesis and evaluation of antiproliferative activity against select cancer cell linesJonathan A Stefely, Rahul Palchaudhuri, Patricia A Miller, et al.Biorxiv : the Preprint Server for Biology|September 21, 2023
CD45-antibody-drug conjugate clears tissue resident myeloid cells from their niches enabling therapeutic adoptive cell transferKarin Gustafsson, Catherine Rhee, Vanessa Frodermann, et al.Pageof 3